Home / Authors / Pickett,

Books by Pickett,

All books by this author

191 books found — Page 6 of 6
Sterility problems and OOS stability results trip up Sanofi Pasteur.(Biologics): An article from: Validation Times
Sterility problems and OOS stability results trip up Sanofi…
By: Joseph Pickett
View Details
Antibiotic prophylaxis. Part I: recommendations of the British Society for Antimicrobial Chemotherapy Working Party.(EVIDENCE FOR PRACTICE): An article from: Canadian Journal of Dental Hygiene
Antibiotic prophylaxis. Part I: recommendations of the Brit…
By: Frieda Pickett
View Details
12-item 483 for CI highlights examples of poor trial site oversight.(Clinical investigators): An article from: Bioresearch Monitoring Alert
12-item 483 for CI highlights examples of poor trial site o…
By: Joseph Pickett
View Details
OOS results, media hold-time specifications, flawed validation reports net IDEC 10-item 483.(Biologics): An article from: Validation Times
OOS results, media hold-time specifications, flawed validat…
By: Joseph Pickett
View Details
Biogen cited for cleaning/autoclave validation, faulty filter extractable studies.(Human drugs): An article from: Validation Times
Biogen cited for cleaning/autoclave validation, faulty filt…
By: Joseph Pickett
View Details
Validation flaws and lack of instrument calibration net 9-item 483.(Human/animal drugs): An article from: Validation Times
Validation flaws and lack of instrument calibration net 9-i…
By: Joseph Pickett
View Details
The Wooden Horse: Or America Menaced By a Prussianized Trade (Classic Reprint)
The Wooden Horse: Or America Menaced By a Prussianized Trad…
By: Deets Pickett
View Details
The wooden horse: or, America menaced by a Prussianized trade
The wooden horse: or, America menaced by a Prussianized tra…
By: Deets Pickett
View Details
Formulation composition of botulinum toxins in clinical use.(ORIGINAL ARTICLES)(Report): An article from: Journal of Drugs in Dermatology
Formulation composition of botulinum toxins in clinical use…
By: Andy Pickett, Karen Perrow
View Details
O'Farrell slapped with 13-item 483 for instrument calibration flaws; owner blasts agency.: An article from: Validation Times
O'Farrell slapped with 13-item 483 for instrument cali…
By: Joseph Pickett
View Details
The Prophetic Romance
The Prophetic Romance
By: Fuchsia Pickett
View Details
The Negro Problem: Abraham Lincoln's Solution
The Negro Problem: Abraham Lincoln's Solution
By: William Passmore Pickett
View Details
Kunnoo Sperits And Others V1 (1900)
Kunnoo Sperits And Others V1 (1900)
By: LaSalle Corbell Pickett
View Details
Colonial Families Of The Southern States Of America: A History And Genealogy Of Colonial Families Who Settled In The Colonies Prior To The Revolution...
Colonial Families Of The Southern States Of America: A Hist…
By: Stella Pickett Hardy
View Details
Rush
Rush
By: Shaheta S Pickett
View Details
New guidance on inactives used in generics to be released.(Excipients): An article from: Validation Times
New guidance on inactives used in generics to be released.(…
By: Joseph Pickett
View Details
23-item 483 issued to Advanced Bionics for quality audits, process validation and risk analysis faults.(Medical devices): An article from: Validation Times
23-item 483 issued to Advanced Bionics for quality audits, …
By: Joseph Pickett
View Details
The Greatest Texas Sports Stories You've Never Heard
The Greatest Texas Sports Stories You've Never Heard
By: Al Pickett
View Details
Mammalian cell technology improving, expert notes; 1-4g/L realized now, 5-10g/L expected soon.(Biotech): An article from: Validation Times
Mammalian cell technology improving, expert notes; 1-4g/L r…
By: Joseph Pickett
View Details
God's Purpose For You: Answer life's five key questions
God's Purpose For You: Answer life's five key que…
By: Fuchsia Pickett
View Details
FDA GMP inspections tend to focus on the '6 P's', says Novartis QA representative.(Special Report: Surviving FDA GMP Inspections): An article from: Inspection Monitor
FDA GMP inspections tend to focus on the '6 P's&#…
By: Joseph Pickett
View Details
Validity of some MDS Pharma studies questioned by agency; pending NDAs could be delayed.(Compliance/enforcement): An article from: BioResearch Compliance Report
Validity of some MDS Pharma studies questioned by agency; p…
By: Joseph Pickett
View Details
MDS Pharma Services slapped with 3-item 483 concerning contamination following bioequivalence audit.(CROs): An article from: Bioresearch Monitoring Alert
MDS Pharma Services slapped with 3-item 483 concerning cont…
By: Joseph Pickett
View Details
Nine-item 483 for Positron for calibration and quality audit problems.(Medical devices): An article from: Validation Times
Nine-item 483 for Positron for calibration and quality audi…
By: Joseph Pickett
View Details
Presence of particulate matter in vials top reason for product recalls, Pfizer executive reports at PDA conference.(Recalls): An article from: Validation Times
Presence of particulate matter in vials top reason for prod…
By: Joseph Pickett
View Details
From Misery to Ministry: My Journey to Forgiveness
From Misery to Ministry: My Journey to Forgiveness
By: Walterine A. Pickett
View Details
Clinical trials must be registered if research is funded by pharma industry.(Registeries): An article from: BioResearch Compliance Report
Clinical trials must be registered if research is funded by…
By: Joseph Pickett
View Details
Andrx Pharma on receiving end of 9-item 483 for OOS, QC violations, control procedures.: An article from: Validation Times
Andrx Pharma on receiving end of 9-item 483 for OOS, QC vio…
By: Joseph Pickett
View Details
FDA gives pharma companies regulatory relief as they implement PAT.(Process analytical technology): An article from: Validation Times
FDA gives pharma companies regulatory relief as they implem…
By: Joseph Pickett
View Details
Big pharma to begin rollout of SAFE electronic sig system in 2007.(Electronic records): An article from: Validation Times
Big pharma to begin rollout of SAFE electronic sig system i…
By: Joseph Pickett
View Details
Part 11 rears its head in Draxis Pharma 3-item 483.(Human drugs): An article from: Validation Times
Part 11 rears its head in Draxis Pharma 3-item 483.(Human d…
By: Joseph Pickett
View Details